Skip to main content

Advertisement

Log in

A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy

  • Case Report
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

This report describes a case of subacute stent thrombosis (SAT) after drug-coated balloon (DCB). A 79-year-old male was investigated for stable angina. An in-stent restenosis (ISR) lesion was detected by coronary angiography. A skin reaction related to the anti-platelet agent thienopyridine was also observed at this time. Therefore, DCB was used to treat the ISR lesion under single anti-platelet therapy (aspirin). However, 3 days after percutaneous coronary intervention, SAT occurred. OCT did not reveal the underlying cause of SAT. Further data are needed to clarify the optimal duration of dual anti-platelet therapy after DCB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5(3):323–30.

    Article  PubMed  Google Scholar 

  2. Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol. 2012;59(15):1377–82.

    Article  CAS  PubMed  Google Scholar 

  3. Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4(2):149–54.

    Article  PubMed  Google Scholar 

  4. Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cariothorac Surg. 2014;46(4):517–92.

    Article  Google Scholar 

  5. Joner M, Byrne RA, Lapointe JM, Radke PW, Bayer G, Steigerwald K, et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost. 2011;105:864–72.

    Article  CAS  PubMed  Google Scholar 

  6. Gao S, Sheb J, Mukku VK, Wang MJ, Akhtar M, et al. Efficacy of drug-eluting balloons for patients with in-stent restenosis: a meta-analysis of 8 randomized controlled trials. Angiology. 2015;0003319715611826.

  7. Zeymer U, Waliszewski M, Spiecker M, Gastmann O, Faurie B, Ferrari M, et al. Prospective ‘real world’ registry for the use of the ‘PCB only’ strategy in small vessel de novo lesions. Heart. 2014;100:311–6.

    Article  CAS  PubMed  Google Scholar 

  8. Edouard C, Laurent L, Gary SM, Jun-ichi Augusto DP, Lowell FS, et al. Predictors of subacute stent thrombosis results of a systematic intravascular ultrasound study. Circulation. 2003;108:43–7.

    Article  Google Scholar 

  9. Stähli BE, Camici GG, Steffel J, Akhmedov A, Shojaati K, et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res. 2006;99(2):149–55.

    Article  PubMed  Google Scholar 

  10. Zhang S, Sun C, Hu H, He Y, Yao Y et al. Effects of paclitaxel on the ability of aspirin and clopidogrel to inhibit platelet aggregation. Clin Appl Thromb Hemost. 2015;1076029615576740.

  11. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381(9865):461–7.

    Article  CAS  PubMed  Google Scholar 

  12. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol. 1986;137:1532–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuzo Kagawa.

Ethics declarations

Conflict of interest

None.

Ethics

The patient provided signed informed consent for our treatment and have given informed consent.

We have conformed to institutional guidelines.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kagawa, Y., Shiode, N., Kawase, T. et al. A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy. Cardiovasc Interv and Ther 32, 170–173 (2017). https://doi.org/10.1007/s12928-016-0386-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-016-0386-0

Keywords

Navigation